Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
This study has been completed.
Sponsor:
Therakos
Collaborators:
M.D. Anderson Cancer Center
Boston Medical Center
University of Pittsburgh
Case Western Reserve University
Vanderbilt University
University of Minnesota - Clinical and Translational Science Institute
Rush University Medical Center
Information provided by (Responsible Party):
Therakos
ClinicalTrials.gov Identifier:
NCT00221039
First received: September 13, 2005
Last updated: December 5, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |